At close: December 13 at 4:00:02 PM EST
After hours: December 13 at 6:40:53 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 3 | 11 | 10 |
| Avg. Estimate | -1.26 | -1.21 | -5.24 | -5.2 |
| Low Estimate | -1.47 | -1.25 | -5.48 | -6.71 |
| High Estimate | -0.59 | -1.16 | -4.56 | -3.85 |
| Year Ago EPS | -1.38 | -1.33 | -5.45 | -5.24 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 3 | 16 | 15 |
| Avg. Estimate | 10.38M | 677.33k | 13.86M | 54.96M |
| Low Estimate | -- | -- | 1.5M | 15.83M |
| High Estimate | 74M | 2.03M | 75.55M | 164.6M |
| Year Ago Sales | 1.67M | 835k | 7.53M | 13.86M |
| Sales Growth (year/est) | 520.99% | -18.88% | 84.13% | 296.37% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.95 | -1.17 | -0.91 | -1.24 |
| EPS Actual | -1.38 | -1.33 | -1.31 | -1.36 |
| Difference | -0.43 | -0.16 | -0.4 | -0.12 |
| Surprise % | -44.91% | -13.20% | -44.38% | -9.26% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.26 | -1.21 | -5.24 | -5.2 |
| 7 Days Ago | -1.26 | -1.18 | -5.26 | -5.2 |
| 30 Days Ago | -1.32 | -1.32 | -5.32 | -5.19 |
| 60 Days Ago | -1.32 | -1.32 | -5.2 | -4.98 |
| 90 Days Ago | -1.32 | -1.27 | -5.2 | -4.98 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 1 | 1 |
| Up Last 30 Days | 4 | 2 | 2 | 2 |
| Down Last 7 Days | -- | 2 | -- | -- |
| Down Last 30 Days | 6 | 2 | 8 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CYTK | 8.84% | 8.77% | 3.78% | 0.81% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/2/2024 |
| Reiterates | Needham: Buy to Buy | 12/2/2024 |
| Maintains | Mizuho: Outperform to Outperform | 11/21/2024 |
| Reiterates | Needham: Buy to Buy | 11/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/19/2024 |
Related Tickers
BBIO BridgeBio Pharma, Inc.
27.49
-0.65%
CRNX Crinetics Pharmaceuticals, Inc.
53.66
-3.52%
BPMC Blueprint Medicines Corporation
93.19
+0.66%
MDGL Madrigal Pharmaceuticals, Inc.
304.50
+0.67%
ASMB Assembly Biosciences, Inc.
15.38
+0.20%
INSM Insmed Incorporated
71.63
-0.58%
EWTX Edgewise Therapeutics, Inc.
27.62
-1.88%
ARGX argenx SE
607.21
+0.63%
ACLX Arcellx, Inc.
83.80
+0.46%
PCVX Vaxcyte, Inc.
87.72
-0.17%